Mylin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -1.66%
- Profit Growth 1.97%
- Ebitda 513.99%
- Net Worth 29.77%
- Total Assets -5.27%
About Mylin Pharmaceuticals
Mylin Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 October 2014 and has a history of Ten years and three months. Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjoy Das and Chittithoti Soma serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100AP2014PTC095548
-
Company No.
095548
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Oct 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Mylin Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjoy Das
|
Director | 03-Sep-2015 | Current |
|
Chittithoti Soma
|
Director | 10-Feb-2018 | Current |
Financial Performance of Mylin Pharmaceuticals.
Mylin Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.66% decrease. The company also saw a slight improvement in profitability, with a 1.97% increase in profit. The company's net worth Soared by an impressive increase of 29.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mylin Pharmaceuticals?
In 2019, Mylin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Darpan Edutainment Estate Private LimitedChittithoti Soma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mylin Pharmaceuticals?
Unlock and access historical data on people associated with Mylin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mylin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mylin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
